Type 2 Drug Preferences Sep 30, 20172,158 views Share Facebook Twitter LinkedIn Which new drug do you prefer for a second-line therapy for a patient with type 2 patient diabetes? GLP-1 Agonist SGLT-2 Inhibitor Long-acting insulin TZD Other View Results Loading ...